Argentina Radiotherapy Market Overview, 2031

Key Insights

• The Argentine radiotherapy market operates within a mixed public-private healthcare system, with significant investment in technology modernisation and infrastructure expansion. The Hospital Oncológico Marie Curie in Buenos Aires has incorporated the first state-of-the-art linear accelerator in the public health system of the city, representing an investment exceeding USD 4 million .
• External Beam Radiotherapy (EBRT) constitutes the largest therapy segment, supported by an installed base of linear accelerators across public and private facilities. The Centro Privado de Radioterapia in Río Cuarto has added a third linear accelerator, placing it among the few services in Argentina's interior with three accelerators in a single facility .
• Radiotherapy systems and equipment represent the largest offering segment, with the market characterised by significant public and private investment. Recent investments include the Hospital Garrahan's Elekta Evo LINAC, the first adaptive radiotherapy technology in Latin America designed specifically for paediatric patients, as part of a broader ARS 30 billion hospital investment plan .
• Hospitals and integrated cancer centres are the largest end-user segment, though geographic distribution is concentrated in major urban centres. The Centro Privado de Radioterapia in Río Cuarto serves patients from provinces including Jujuy, Tucumán, Santiago del Estero, and Catamarca, with between eight and fourteen patients per week arriving for brachytherapy treatments .
• Workforce development is a critical priority. The National University of Río Negro, National University of Cuyo, and the National Atomic Energy Commission have established a joint Specialisation in Radiotherapy programme, addressing the limited options for specialised training with university recognition and promoting equitable distribution of specialists across the country .

Market Outlook

• According to the research report, "Argentina Radiotherapy Market Overview, 2031," published by Bonafide Research, the Argentina Radiotherapy market was valued at more than USD 40 Million in 2025. This valuation reflects the scale of Argentina's mixed public-private radiotherapy infrastructure, with equipment procurement and maintenance funded through both government budgets and private investment.
• The market is expected to benefit from continued government investment in radiotherapy infrastructure. The Hospital Garrahan has received a new Elekta Evo linear accelerator, the first adaptive radiotherapy technology in Latin America designed for paediatric patients, with a broader ARS 30 billion investment plan announced for the hospital . The Ministry of Health of Tucumán has invested over ARS 2.5 billion in a new radiotherapy unit at the Hospital Centro de Salud Zenón J. Santillán .
• Technology modernisation is accelerating across both public and private sectors. The Hospital Oncológico Marie Curie in Buenos Aires has incorporated the first state-of-the-art linear accelerator in the public health system of the city, enabling precision radiotherapy treatments previously only available in private centres . The Centro Privado de Radioterapia in Río Cuarto has added a third accelerator to ensure treatment continuity and respond to growing demand .
• The market is also characterised by significant workforce development initiatives. The National Atomic Energy Commission, in partnership with the National University of Río Negro and National University of Cuyo, has established a Specialisation in Radiotherapy programme, integrating academic, scientific, and clinical training across multiple regions .
• Long-term growth is supported by sustained public and private investment. The Oulton Institute has invested USD 12 million in a new biomolecular medicine facility in Córdoba, incorporating advanced nuclear medicine equipment . The provincial government of Tucumán is evaluating the incorporation of electronic brachytherapy technology .

Market Dynamics

Driver: Sustained Public and Private Investment in Technology Modernisation
The primary driver of the Argentine radiotherapy market is sustained investment in technology modernisation across both public and private sectors. The Hospital Garrahan has received an Elekta Evo linear accelerator, the first adaptive radiotherapy technology in Latin America designed for paediatric patients, as part of a broader ARS 30 billion hospital investment plan . The Hospital Oncológico Marie Curie in Buenos Aires has incorporated the first state-of-the-art linear accelerator in the public health system of the city, representing an investment exceeding USD 4 million . The Ministry of Health of Tucumán has invested over ARS 2.5 billion in a new radiotherapy unit with a last-generation linear accelerator, positioning the province among the country's reference centres . Private sector investment is also substantial: the Oulton Institute has invested USD 12 million in a new biomolecular medicine facility in Córdoba . This sustained investment cycle ensures consistent demand for radiotherapy equipment, installation services, training, and comprehensive maintenance contracts.

Challenge: Infrastructure Disparities and Equipment Dependency
A significant challenge facing the Argentine radiotherapy market is the regional disparity in equipment availability and the complexity of maintaining advanced systems. In many cities in Argentina's interior, there is only one linear accelerator or no radiotherapy services at all, forcing patients to travel to other provinces for treatment when equipment fails . Equipment failures are a recurring issue due to the technological complexity of linear accelerators, which require imported parts particularly from the United States with repair times that can extend to ten days or more . This creates significant treatment interruptions for patients who require continuous radiotherapy over several weeks. Additionally, limited accessibility and affordability of advanced radiotherapy technologies in rural and underserved areas remain prominent issues, compounded by economic constraints and funding limitations that impact investment in equipment and technology upgrades . The shortage of skilled radiation oncologists and medical physicists further constrains service delivery .



Trend: Workforce Development and Regional Expansion
A major trend shaping the Argentine radiotherapy market is the expansion of workforce training and regional service delivery. The National Atomic Energy Commission, in partnership with the National University of Río Negro and the National University of Cuyo, has established a joint Specialisation in Radiotherapy programme. This initiative addresses the limited options for specialised training with university recognition and aims to promote equitable distribution of specialists across the country . The programme integrates academic institutions, scientific-technological environments through the Balseiro Institute and CNEA, and high-complexity clinical settings in Patagonia, Cuyo, and Buenos Aires provinces . This workforce development initiative is expected to support the expansion of radiotherapy services into underserved regions and improve treatment quality across Argentina.

Policies

• The National Atomic Energy Commission, in partnership with the National University of Río Negro and the National University of Cuyo, has established a joint Specialisation in Radiotherapy programme. The programme integrates clinical practice with scientific-technological development, innovation, and translational research in radiotherapy, medical physics, and artificial intelligence applied to oncology .
• The National Plan for Nuclear Medicine, promoted by the CNEA, supports the expansion of radiotherapy services. The Hospital Garrahan's Elekta Evo linear accelerator acquisition is framed within this plan .
• The Ministry of Health of Tucumán has invested over ARS 2.5 billion in a new radiotherapy unit at the Hospital Centro de Salud Zenón J. Santillán, reflecting provincial-level investment in high-complexity oncology care .
• Public-private articulation is being used to optimise resources and provide responses. The Tucumán radiotherapy unit results from a nearly two-decade collaboration between the public hospital and VIDT Oncología Radiante, enabling public patients to access treatments comparable with the country's leading specialised centres .
• The Autonomous City of Buenos Aires Ministry of Health has invested over USD 4 million in the Hospital Oncológico Marie Curie's linear accelerator, including a 420-square-metre shielded room, equipment acquisition, and a planning tomograph .
• The Nuclear Regulatory Authority provides oversight for radiotherapy facilities, requiring installations to be authorised by the ARN and respective provincial Ministries of Health .
• Government policies aim to improve patient access to advanced radiotherapy techniques through healthcare policies, infrastructure investments, and technology subsidies .

Segment Analysis

Argentina Radiotherapy Market By Therapy Type
• External Beam Radiotherapy (EBRT): This is the largest therapy segment, supported by the installed base of linear accelerators across public and private facilities. The Hospital Oncológico Marie Curie's new LINAC enables high-precision radiotherapy with millimetric accuracy . The Centro Privado de Radioterapia in Río Cuarto operates three accelerators two high-complexity and one simpler to cover the full spectrum of treatments . The segment is driven by the transition from cobalt-60 units to modern LINACs; the Marie Curie's LINAC replaces a cobalt bomb, which disperses energy broadly, while the LINAC concentrates the radiation beam like a laser, enabling higher doses without increasing toxicity .
• Internal / Brachytherapy: This segment is clinically essential, particularly for gynaecological cancers including cervical cancer. The Centro Privado de Radioterapia performs over 7,000 brachytherapy "shots" annually, positioning it among the country's most active centres in this specialty . The centre receives between eight and fourteen patients per week from provinces including Jujuy, Tucumán, Santiago del Estero, and Catamarca for brachytherapy, which is often unavailable in those regions . The Ministry of Health of Tucumán is evaluating the incorporation of electronic brachytherapy technology, a mobile device that emits no radiation and works with a tomograph, currently available in countries including the United States, Brazil, and Spain .
• Systemic Radiotherapy: This is the fastest-growing therapy segment, driven by the emergence of novel radiopharmaceuticals and targeted radionuclide therapies. The Oulton Institute's new biomolecular medicine facility includes a Cyclotron Iba Cyclone KIUBE for producing radiopharmaceuticals for PET diagnostics . The National Atomic Energy Commission's involvement in radiotherapy and nuclear medicine supports the development of radiopharmaceutical capabilities .

Argentina Radiotherapy Market By Offering
• Radiotherapy Systems/Equipment: This segment holds the largest market share by revenue, driven by high capital costs and sustained public and private investment. Recent procurement demonstrates significant capital expenditure: the Hospital Garrahan's Elekta Evo system, designed specifically for paediatric patients, represents a multi-million dollar investment ; the Hospital Oncológico Marie Curie's LINAC investment exceeded USD 4 million ; the Oulton Institute invested USD 12 million in its biomolecular medicine facility ; and the Tucumán radiotherapy unit involved over ARS 2.5 billion . Major equipment suppliers include Elekta and Varian Medical Systems, with INVAP providing construction services for the Garrahan facility .
• Software & Services: This is the fastest-growing segment, reflecting increasing digitalisation of radiation oncology. The software component includes advanced treatment planning systems the Elekta Evo system features online adaptive radiotherapy, enabling real-time treatment adjustments based on anatomical changes . The services component encompasses installation, comprehensive maintenance, clinical training, and physics support. The Garrahan installation includes a calibration phase and professional training . The Centro Privado de Radioterapia's need for imported parts and specialised technical resources highlights the importance of maintenance services .

Argentina Radiotherapy Market By Application
• Breast Cancer: This is a major application segment, with breast cancer ranking among the most frequent malignancies in Argentina. The Hospital Oncológico Marie Curie treats the most prevalent cancers in Argentina, including breast cancer .
• Cervical Cancer: A significant application area, with brachytherapy playing a critical role. The Centro Privado de Radioterapia receives numerous patients from northern provinces for cervical cancer brachytherapy, a disease with higher incidence in regions with high levels of social vulnerability .
• Prostate Cancer: A significant application area, with the Marie Curie LINAC's precision capabilities particularly beneficial for prostate cancer treatment .
• Lung Cancer: A growing application segment, with advanced radiotherapy techniques improving outcomes. The Marie Curie LINAC is indicated for lung tumours .
• Head & Neck Cancer: This is a critical application requiring highly conformal radiation delivery, with the Marie Curie's LINAC precision benefiting head and neck cancer patients .
• Paediatric Cancers: The Hospital Garrahan is the only paediatric centre in Argentina with a radiotherapy service, treating approximately 50% of children with cancer in the country . The Elekta Evo system, designed specifically for paediatric patients, reduces long-term side effects and protects healthy tissue during child development .
• Other Applications: Includes central nervous system/brain tumours , gastrointestinal cancers, and haematological malignancies.

Argentina Radiotherapy Market By End User
• Hospitals & Integrated Cancer Centres: This is the largest end-user segment, operating within the public healthcare system. Major centres include the Hospital Garrahan (paediatric, unique in the country), Hospital Oncológico Marie Curie (Buenos Aires public system), and the Hospital Centro de Salud Zenón J. Santillán (Tucumán) . These institutions manage complex equipment fleets and are the primary beneficiaries of public investment programmes. The Garrahan treats 50% of the country's children with cancer, with a five-year survival rate exceeding 70% .
• Standalone Radiotherapy Centres: This segment is significant, particularly in the private sector. The Centro Privado de Radioterapia in Río Cuarto operates three LINACs and serves patients from multiple provinces . The Oulton Institute in Córdoba operates a biomolecular medicine facility with advanced nuclear medicine and radiotherapy capabilities . Private facilities are often the only source of advanced radiotherapy in the interior of the country.
• Academic/Research Institutions: This is the fastest-growing segment, reflecting their central role in workforce development. The CNEA, National University of Río Negro, and National University of Cuyo partnership is establishing a Specialisation in Radiotherapy programme, integrating academic, scientific, and clinical training . The Balseiro Institute contributes to innovation in applied sciences, medical physics, and emerging technologies in radiotherapy .
• Other Healthcare Facilities: Includes regional hospitals and community-based centres. Many cities in Argentina's interior have only one LINAC or no radiotherapy services, creating significant access challenges .

Argentina Radiotherapy Market Economics

• Equipment procurement in Argentina is conducted through government tenders for public facilities and direct private investment. Recent investments demonstrate substantial capital expenditure: the Marie Curie LINAC investment exceeded USD 4 million ; the Oulton Institute invested USD 12 million ; and the Tucumán radiotherapy unit involved over ARS 2.5 billion .
• Linear accelerator costs are substantial, with systems requiring significant infrastructure investment. The Marie Curie installation included a 420-square-metre shielded room specifically designed for the LINAC, along with a planning tomograph .
• Maintenance and repair costs are significant challenges. When a LINAC breaks down in Argentina, many components must be imported, and specialised technical resources are limited, potentially leaving equipment out of service for ten days or more . This creates treatment continuity risks, particularly for centres with only one accelerator.
• The economic impact of equipment failure is substantial. When an accelerator fails in cities with only one unit, patients must travel to other provinces to continue treatment . The Centro Privado de Radioterapia in Río Cuarto has become a reference point for multiple regions, receiving patients from provinces including Jujuy, Tucumán, Santiago del Estero, and Catamarca when their local equipment is unavailable .
• Workforce economics present challenges. The shortage of skilled professionals and limited specialised training options constrain service delivery . In the private sector, salaries typically exceed public sector wages by approximately 25%, creating workforce mobility challenges .
• The cost of cybersecurity and software modernisation is an emerging factor, with connected radiotherapy devices requiring ongoing patch management. The Elekta Evo system's adaptive radiotherapy capabilities highlight the software-dependent nature of modern radiotherapy .

Market Outlook by Infrastructure, Investment and Industry Development

• The Hospital Garrahan has received an Elekta Evo linear accelerator, the first adaptive radiotherapy technology in Latin America designed for paediatric patients. The installation, part of a broader ARS 30 billion hospital investment plan, will enable treatments with millimetric precision, lower toxicity, and online adaptive radiotherapy that adjusts in real time to patient anatomical changes .
• The Hospital Oncológico Marie Curie in Buenos Aires has incorporated the first state-of-the-art linear accelerator in the public health system of the city, representing an investment exceeding USD 4 million. The LINAC replaces a cobalt bomb, enabling more precise and effective treatments for lung, head and neck, prostate, and brain cancers .
• The Ministry of Health of Tucumán has invested over ARS 2.5 billion in a new radiotherapy unit at the Hospital Centro de Salud Zenón J. Santillán, featuring a last-generation accelerator unique in northern Argentina. The unit results from a nearly two-decade public-private collaboration . The ministry is also evaluating the incorporation of electronic brachytherapy technology .
• The Centro Privado de Radioterapia in Río Cuarto has added a third linear accelerator, placing it among the few interior Argentine services with three accelerators. The centre serves patients from multiple provinces and performs over 7,000 brachytherapy shots annually .
• The Oulton Institute has invested USD 12 million in a new biomolecular medicine facility in Córdoba, incorporating advanced nuclear medicine equipment including a PET/CT Siemens Biograph Horizon, Spect/CT Siemens Symbia Pro.specta Q3, and a Cyclotron Iba Cyclone KIUBE .
• Workforce development is advancing through the CNEA-UNRN-UNCuyo Specialisation in Radiotherapy programme. The programme integrates academic institutions, the Balseiro Institute, and clinical practice centres in Patagonia, Cuyo, and Buenos Aires provinces, aiming to address the limited options for specialised training and promote equitable distribution of specialists .
• The long-term outlook remains positive as public and private investment drives technology modernisation, workforce development programmes expand specialised training, and infrastructure expansion improves access to advanced radiotherapy across Argentina's healthcare system. However, addressing regional disparities and equipment dependency challenges will be essential to ensuring equitable access and treatment continuity across all provinces.



Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• Radiotherapy Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Therapy Type
• External Beam Radiotherapy (EBRT)
• Internal / Brachytherapy
• Systemic Radiotherapy

By Offering
• Radiotherapy Systems/Equipment
• Software & Services

By Application
• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Head & Neck Cancer
• Central Nervous System / Brain
• Gastro-intestinal
• Other Applications

By End User

• Hospitals & Integrated Cancer Centers
• Standalone Radiotherapy Centers
• Academic/Research Institutions
• Other Healthcare Facilities